ArticleJournal of virology2026
Divergence in poxvirus-encoded E3-like proteins can dictate poxvirus activation of cellular necroptosis.
Article in Journal of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Poxviruses encode a plethora of proteins adapted to diverse cellular responses against viruses. The poxvirus-encoded E3-like proteins are multifunctional, regulating diverse cellular antiviral responses. The canonical Vaccinia E3-like proteins have two domains: an N-terminal Z-form nucleic acid-binding domain (Zα-BD) and a C-terminal double-stranded RNA-binding domain (dsRNA-BD). Using protein sequence and structural homology modeling, we identified dsRNA-BD-fold-containing proteins in all the poxviruses except avipoxviruses, salmon poxvirus, and entomopoxviruses. Furthermore, we show that the acquisition of these proteins likely happened under three distinct events and can be classified into three categories: (i) the E3-like proteins with dsRNA-BD with the presence or absence of the N-terminal domain; (ii) unconventional/putative dsRNA-BD-fold-like proteins, present in macropoxvirus and molluscipoxvirus, and (iii) the dsRNA-BD-containing protein present in crocodile poxvirus. Members of leporipoxvirus, waddenpoxvirus, cetaceanpoxvirus, and selected members of orthopoxvirus contain E3-like proteins missing the N-terminal Zα-BD required for necroptosis inhibition. Using AlphaFold, we also show that the Zα-BD of chordopoxviruses, E3-like proteins, is structurally more variable than the dsRNA-binding domain. Compared to orthopoxviruses that inhibit necroptosis and contain an N-terminus Zα-BD, our results show that leporipoxviruses induce receptor-interacting protein kinase (RIPK) RIPK1- and RIPK3-mediated necroptosis in human and mouse necroptosis-competent cell lines. These data suggest that leporipoxviruses lack countermeasures against necroptosis, unlike orthopoxviruses, which encode multiple key regulators of necroptosis, possibly due to a lack of selective pressure in their lagomorph host species.IMPORTANCEThe evolutionary arms race between viruses and their hosts has led to the viral acquisition of genes that antagonize the host's antiviral defenses. However, related viral and host proteins have evolved under positive, purifying, and neutral selection. Poxvirus-encoded E3-like proteins play a pivotal role in regulating the host's cellular antiviral and apoptotic responses. The two domains of canonical E3-like proteins, an N-terminal Z-form nucleic acid-binding domain (Zα-BD) and a C-terminal double-stranded RNA-binding domain (dsRNA-BD), have evolved under varying host immune selection pressures. Here, we demonstrate that the dsRNA-BD is structurally conserved among E3 orthologs, whereas the Zα-BD, involved in regulating necroptosis, exhibits structural diversity and is absent in some poxviruses. Leporipoxviruses, which lack Zα-BD-containing proteins and evolved in species without functional necroptosis, do activate necroptosis in necroptotic-competent cells. Our study thus highlights that a lack of selective pressure from the host can shape viral countermeasures and viral divergence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.